LabOne, Inc. Form 8-K dated March 2, 2004

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IrJMddz7/qasna/sP6fqgeNzs86Lb/jxmz2PCF/F3kSxdbNza2JQy2ywyLSrdD4r 4foleU2X0IQliOj1FBx6uw== 0000830158-04-000013.txt : 20040302 0000830158-04-000013.hdr.sgml : 20040302 20040302101514 ACCESSION NUMBER: 0000830158-04-000013 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040302 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABONE INC/ CENTRAL INDEX KEY: 0000830158 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 431039532 STATE OF INCORPORATION: MO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 333-92137 FILM NUMBER: 04641236 BUSINESS ADDRESS: STREET 1: 10101 RENNER BLVD STREET 2: P. O. BOX 7568 CITY: LENEXA STATE: KS ZIP: 66219 BUSINESS PHONE: 9138881770 MAIL ADDRESS: STREET 1: 10101 RENNER BLVD STREET 2: X CITY: LENEXA STATE: KS ZIP: 66219 FORMER COMPANY: FORMER CONFORMED NAME: LAB HOLDINGS INC DATE OF NAME CHANGE: 19980406 FORMER COMPANY: FORMER CONFORMED NAME: SEAFIELD CAPITAL CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEAFIELD CAPTIAL CORP DATE OF NAME CHANGE: 19910520 8-K/A 1 nwt8k2.htm LabOne, Inc. Form 8-K dated March 2, 2004 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: March 2, 2004

Commission file number: 0-16946

LabOne, Inc.

10101 Renner Blvd.

Lenexa, Kansas 66219

(913) 888-1770

Incorporated in Missouri

I.R.S. Employer Identification Number: 43-1039532

Item 9. Regulation FD Disclosure

(Amended to correct previous headline)

LabOne Completes Acquisition of Northwest Toxicology

LabOne, Inc. (Nasdaq: LABS), announced today that it has completed the purchase of the assets of the drug testing division, Northwest Toxicology, from NWT Inc., Salt Lake City. The purchase price is $10.0 million subject to adjustment based on net working capital at closing, plus an earn-out for up to seven years based on the performance of the continuing laboratory operations in Salt Lake City less related financing. Prior to closing, Northwest Toxicology announced it would suspend hair testing for drugs of abuse on March 31, 2004, due to recent FDA guidance and anticipated regulatory changes. The acquisition will result in additional urine and oral fluid testing volumes directed to LabOne, and further the Company's capabilities to include drugs of abuse testing in blood, expanded specimen validity testing, medical professional and other esoteric drug testing.

Although LabOne expects to transition most of Northwest Toxicology's traditional urine and oral fluid testing to its Lenexa facility during 2004, the Northwest Toxicology laboratory in Salt Lake City will be maintained as a SAMHSA-certified laboratory. The acquisition is expected to add approximately $11 million in annual revenues, and to be accretive to earnings.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

LabOne, Inc.

Date: March 2, 2004

By /s/ John W. McCarty
John W. McCarty
Executive V.P. and Chief Financial Officer

-----END PRIVACY-ENHANCED MESSAGE-----